ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #8,261Hybrid

Prostaglandins & Other Lipid Mediators

Acronym:polm
•
Abbreviation (ISO):PROSTAG OTH LIPID M
•
Identifier (ISSN):1098-8823(Print)
•
Publisher:Elsevier Inc.
Clarivate IF (2026)
2.6↑ +0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Prostaglandins & Other Lipid Mediators

WoS Q3
12452.9920182.2520192.2820203.0720213.8120222.920232.520242.520252.62026
Annual Impact Factor Metric
Current (2026):2.6
Scopus SJR & RankScopus Q2
0.699
#8,261

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
92

92 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate4%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
56articles/year
16.76% Gold OA•82.86% Original Research

Aims & Scope

Prostaglandins & Other Lipid Mediators is the original and foremost journal dealing with prostaglandins and related lipid mediator substances. It includes basic and clinical studies related to the pharmacology, physiology, pathology and biochemistry of lipid mediators. Prostaglandins & Other Lipid Mediators invites reports of original research, mini-reviews, reviews, and methods articles in the basic and clinical aspects of all areas of lipid mediator research: cell biology, developmental biology, genetics, molecular biology, chemistry, biochemistry, physiology, pharmacology, endocrinology, biology, the medical sciences, and epidemiology. Prostaglandins & Other Lipid Mediators also accepts proposals for special issue topics. The Editors will make every effort to advise authors of the decision on the submitted manuscript within 3-4 weeks of receipt.

Topics Covered (Recognized by AI)
Chemistry90.3%Biology88.5%Biochemistry84.2%Medicine83.5%Internal medicine80.2%Genetics74.3%Endocrinology62.2%Organic chemistry55.4%Physics52.3%Nuclear magnetic resonance47.9%Enzyme47.8%Receptor39.8%Immunology37.6%Cell biology33.3%Gene26.1%Pharmacology23.6%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Q3
Rank224/328
IndexSCIE
JCRSCIE2026

CELL BIOLOGY

Q3
Rank151/207
IndexSCIE
JCISCIE2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Q4
Rank255/328
IndexSCIE
JCISCIE2026

CELL BIOLOGY

Q3
Rank151/207
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.6
Articles / Year19
Total Citations1
2025
IF2.5
Articles / Year46
Total Citations109
2024
IF2.5
Articles / Year97
Total Citations400
2023
IF2.9
Articles / Year64
Total Citations523
2022
IF3.813
Articles / Year50
Total Citations436

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #8,261Scopus Q2SCImago Profile
Scopus Coverage:1996, 1998-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q2
0.699

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.76

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,133 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations522
3-Year Documents185
Citable Documents184

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate43.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

BiochemistryQ2
PharmacologyQ2
Cell BiologyQ3
PhysiologyQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Biology
Minor Category (Specific Field):
4区BIOCHEMISTRY & MOLECULAR BIOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Prostaglandins & Other Lipid Mediators (acronym: polm, abbr: PROSTAG OTH LIPID M, ISSN: 1098-8823) is a peer-reviewed international scholarly journal in the field of Biology, published by Elsevier Inc. in United States since 1998. The periodical holds a Journal Impact Factor (JIF) of 2.60, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.699 (Q2), an H-index of 92.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 56 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,133 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier Inc.
Publication Language
English
Frequency
Monthly
Founding Year
1998
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: f205bce7-d4d1-4687-a817-506b5a18d70e
Database Updated: 2026-10-16